Drug Discovery Market Research Reports & Industry Analysis

Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.

Understanding the Drug Discovery Market

  • Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
  • We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
  • We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.

Informed Insights: Your Path to Success

Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.

...Show More ...Show Less


Drug Discovery Industry Research & Market Reports

  • Kaposi Sarcoma

    ... at a CAGR of 3.1% over the analysis period 2023-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the ... Read More

  • Krabbe Disease Treatment

    ... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Anticonvulsants Therapy, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$823.5 Million by ... Read More

  • Uterine Cancer Therapeutics and Diagnostics

    ... is expected to reach US$28.2 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Endometrial Carcinomas Therapeutics and Diagnostics, one of the segments analyzed in the report, is expected to ... Read More

  • Ulcerative Colitis Therapeutics

    ... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by ... Read More

  • Antivenoms

    ... of 7.3% over the analysis period 2023-2030. Snakes Species, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More

  • Dermatophytic Onychomycosis Treatment

    ... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Topical Therapy, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.1 Billion by ... Read More

  • Post-Traumatic Stress Disorder (PTSD) Therapeutics

    ... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR ... Read More

  • Anti-Inflammatory Therapeutics

    ... at a CAGR of 4.3% over the analysis period 2023-2030. Anti-Inflammatory Biologics, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$67.7 Billion by the end of ... Read More

  • Opioid Overdose - Pipeline Insight, 2024

    ... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More

  • Global Cystinuria Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032

    ... 2023 – 2032 Global Cystinuria Market was valued at US $110.5 Million in 2022 and is expected to reach ~US $200 Million by 2032, growing at a CAGR of 6.1% during the forecast period 2023-2032. ... Read More

  • Polycystic Ovary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

    ... expected to show positive growth by 2034. For functioning metastatic PCPG, it is recommended to start with alpha blockade before therapy, followed by beta-blockers, calcium channel blockers, and metyrosine as needed. Radical surgical resection is ... Read More

  • Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034

    ... stage Ta, followed by T1 and Tis in the United States, while PUN-LMP accounted for the least prevalent stage, with ~6,800 cases in 2023 NMIBC is an age-associated malignancy, with a median age at diagnosis ... Read More

  • Global Degenerative Disc Disease Market 2024-2028

    ... forecast period. The report on the degenerative disc disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More

  • Cushing`s Syndrome Diagnostics and Treatment

    ... is expected to reach US$819.7 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Cushing`s Syndrome Treatment, one of the segments analyzed in the report, is expected to record a ... Read More

  • Infertility Drugs

    ... at a CAGR of 5.2% over the analysis period 2023-2030. Hormone-Based Therapy, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$5.3 Billion by the end of ... Read More

  • COVID-19 Vaccines

    ... by 2025. The COVID-19 Vaccines market in the U.S. is estimated at 285 Million Doses in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of 1 ... Read More

  • Leukemia Therapeutics

    ... at a CAGR of 5.6% over the analysis period 2023-2030. Chronic Myeloid Leukemia Therapeutics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$9.1 Billion by the ... Read More

  • Drug Discovery Informatics

    ... by 2030, growing at a CAGR of 8.4% over the period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record 7.9% CAGR and reach US$3 Billion by the end ... Read More

  • 22q11.2 Deletion Syndrome - Pipeline Insight, 2024

    ... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More

  • Lichen Planus- Pipeline Insight, 2024

    ... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Lichen ... Read More

  • Idiopathic Membranous Nephropathy Market Insight, Epidemiology And Market Forecast - 2032

    ... States accounted for 90% of the cases, while Japan and Germany represented 2.3% and 2.0% of the cases, respectively. The hypophosphatasia market is set for steady growth, with a robust compound annual growth rate (CAGR) ... Read More

  • Primary Ciliary Dyskinesia Market Insight, Epidemiology And Market Forecast - 2034

    ... 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for the maximum share of the total market in the 7MM, i.e., approximately 80%. The current ... Read More

  • Global T-cell Lymphoma Market 2024-2028

    ... report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More

  • 2024 Global Forecast for Tuberculosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

    ... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More

  • 2024 Global Forecast for Drug Discovery Informatics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

    ... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings